FL
Fulgent Genetics, Inc.
FLGT · NASDAQ
$20.58 -8.33% (-$1.87)
1M +1.88%
Market Cap $584.5M
P/E Ratio -
Div. Yield -
ROE 7.87%
Bulios Fair Price
$14.57
29.2% downside
Current Price
$20.58
Undervalued Fair Value Overvalued
According to Bulios Fair Price, FLGT is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
5/9Valuation
91 /100
Cheap P/S 1.80x
P/B 0.58x
P/E N/A
Growth
1 /100
Declining Rev. growth 19.52%
Book val. growth 4.25%
EPS growth N/A
Profitability
14 /100
Weak Gross margin 35.58%
FCF margin 32.04%
Net margin 26.05%
Quality
4 /100
Poor ROIC 11.05%
Asset turnover 0.30x
ROE 7.87%
Debt
69 /100
Low Debt/Equity 0.01x
Int. coverage -381.71x
Current ratio 6.34x
Stability
30 /100
Unstable Beta 0.93x
Profitable years 0
Rev. volatility 35.08%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about FLGT
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Ming Hsieh
Employees
1,315
Headquarters
El Monte
Upcoming events
06 NOV
Earnings
Upcoming earnings report